The government is examining Pfizer's request for indemnity and will take a decision in the larger interest of people and on merit, NITI Aayog Member (Health) VK Paul said today.

from NDTV News - Topstories https://ift.tt/3oUuaFU
https://ift.tt/eA8V8J